193 related articles for article (PubMed ID: 24696610)
1. Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells.
Wei J; Zhao ZX; Li Y; Zhou ZQ; You TG
World J Gastroenterol; 2014 Mar; 20(12):3287-300. PubMed ID: 24696610
[TBL] [Abstract][Full Text] [Related]
2. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer.
Li DM; Zhang J; Li WM; Cui JT; Pan YM; Liu SQ; Xing R; Lu YY
World J Gastroenterol; 2013 May; 19(18):2781-92. PubMed ID: 23687415
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
Gong Y; Ren J; Liu K; Tang LM
World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
[TBL] [Abstract][Full Text] [Related]
4. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway.
Li C; Liu DR; Li GG; Wang HH; Li XW; Zhang W; Wu YL; Chen L
World J Gastroenterol; 2015 May; 21(20):6215-28. PubMed ID: 26034356
[TBL] [Abstract][Full Text] [Related]
5. Function of chloride intracellular channel 1 in gastric cancer cells.
Ma PF; Chen JQ; Wang Z; Liu JL; Li BP
World J Gastroenterol; 2012 Jun; 18(24):3070-80. PubMed ID: 22791942
[TBL] [Abstract][Full Text] [Related]
6. The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion.
Fujimoto D; Hirono Y; Goi T; Katayama K; Matsukawa S; Yamaguchi A
BMC Cancer; 2010 Aug; 10():443. PubMed ID: 20723226
[TBL] [Abstract][Full Text] [Related]
7. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
8. [Effects of MTA1 on biological behaviors of gastric cancer cells].
Wang JS; Qian HL; Wang HJ; Xu DK
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):580-586. PubMed ID: 30139027
[No Abstract] [Full Text] [Related]
9. Bradykinin Promotes Cell Proliferation, Migration, Invasion, and Tumor Growth of Gastric Cancer Through ERK Signaling Pathway.
Wang G; Sun J; Liu G; Fu Y; Zhang X
J Cell Biochem; 2017 Dec; 118(12):4444-4453. PubMed ID: 28464378
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
Zhang J; Kou YB; Zhu JS; Chen WX; Li S
Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
[TBL] [Abstract][Full Text] [Related]
11. Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro.
Zhang L; Huang H; Wu K; Wang M; Wu B
Mol Biol Rep; 2010 Jul; 37(6):2579-86. PubMed ID: 19728149
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
13. MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer.
Ge S; Zhang H; Deng T; Sun W; Ning T; Fan Q; Wang Y; Wang X; Zhang Q; Zhou Z; Yang H; Ying G; Ba Y
Invest New Drugs; 2019 Oct; 37(5):923-934. PubMed ID: 30607520
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-92b-3p suppresses proliferation, migration, and invasion of gastric cancer SGC-7901 cells by targeting Homeobox D10.
Li C; Huo B; Wang Y; Cheng C
J Cell Biochem; 2019 Oct; 120(10):17405-17412. PubMed ID: 31106881
[TBL] [Abstract][Full Text] [Related]
15. CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation.
Wang J; Hu W; Wu X; Wang K; Yu J; Luo B; Luo G; Wang W; Wang H; Li J; Wen J
Int J Oncol; 2016 May; 48(5):2184-96. PubMed ID: 26983663
[TBL] [Abstract][Full Text] [Related]
16. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ
Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489
[TBL] [Abstract][Full Text] [Related]
17. The role of TRPV1 ion channels in the suppression of gastric cancer development.
Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of ADAM17 modulation in gastric cancer through regulation of the EGFR and TNF-α signalling pathways.
Sun J; Jiang J; Lu K; Chen Q; Tao D; Chen Z
Mol Cell Biochem; 2017 Feb; 426(1-2):17-26. PubMed ID: 27878499
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer.
Wang M; Li C; Yu B; Su L; Li J; Ju J; Yu Y; Gu Q; Zhu Z; Liu B
J Gastroenterol; 2013 Sep; 48(9):1023-33. PubMed ID: 23338485
[TBL] [Abstract][Full Text] [Related]
20. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
